MIGRAINE AND VASODILATION TREATMENT

Title:

MIGRAINE AND VASODILATION TREATMENT

Document Type and Number:

WIPO Patent Application WO2001079270

Kind Code:

A3

Abstract:

The present invention relates to the use of Cystatin in predicting onset of migraines. The invention also relates to the use of Cystatin as a vasodilatory agent. The invention also relates to antagonists to Cystatin for use in preventing and treating migraine attacks.

More Like This:

JPH0223873	PRODUCTION OF RECOMBINANT EUCARYOCYTE HAVING HIGH EXPRESSION LEVEL
WO/1990/002137	RENIN INHIBITORY PEPTIDES CONTAINING SULEPTANIC ACID OR DERIVATIVES THEREOF
WO/2017/151871	METHODS AND COMPOSITIONS FOR THE DETECTION AND DIAGNOSIS OF RENAL DISEASE AND PERIODONTAL DISEASE

Inventors:

LAMEY PHILIP-JOHN (GB)
LUNDY FIONNUALA TERESA (GB)
SHAW CHRISTOPHER (GB)

Application Number:

PCT/GB2001/001683

Publication Date:

September 06, 2002

Filing Date:

April 17, 2001

Export Citation:

Click for automatic bibliography generation Help

Assignee:

UNIV BELFAST (GB)
LAMEY PHILIP-JOHN (GB)
LUNDY FIONNUALA TERESA (GB)
SHAW CHRISTOPHER (GB)

International Classes:

C07K14/81; A61K38/00; (IPC1-7): A61K38/57; C07K14/81; G01N33/68

Domestic Patent References:

WO1994015578A1	1994-07-21
WO2000008159A2	2000-02-17

Other References:

BOBEK L A ET AL: "CYSTATINS - INHIBITORS OF CYSTEINE PROTEINASES", CRITICAL REVIEWS IN ORAL BIOLOGY AND MEDICINE, CRC PRESS, BOCA RATON, FL, US, vol. 3, no. 4, 1992, pages 307 - 332, XP001023530, ISSN: 1045-4411

Download PDF:

View/Download PDF PDF Help

Previous Patent: LIPID BINDING PROTEIN 4

Next Patent: ALBUMIN FUSION PROTEINS